Results 191 to 200 of about 794,896 (338)

Patent Analysis of Dental CBCT Machines. [PDF]

open access: yesInt Dent J
Yeung AWK   +4 more
europepmc   +1 more source

The size distribution of innovations revisited: an application of extreme value statistics to citation and value measures of patent significance [PDF]

open access: yes
This paper focuses on the analysis of size distributions of innovations, which are known to be highly skewed. We use patent citations as one indicator of innovation significance, constructing two large datasets from the European and US Patent Offices at ...
Silverberg,Gerald, Verspagen,Bart
core   +1 more source

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

open access: yesMolecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson   +2 more
wiley   +1 more source

Polysaccharide-Based Drug Carriers-A Patent Analysis. [PDF]

open access: yesGels
Ilić-Stojanović S   +3 more
europepmc   +1 more source

Nanotechnology Publications and Patents: A Review of Social Science Studies and Search Strategies [PDF]

open access: yes
This paper provides a comprehensive review of more than 120 social science studies in nanoscience and technology, all of which analyze publication and patent data. We conduct a comparative analysis of bibliometric search strategies that these studies use
Huang, Can, Notten, Ad, Rasters, Nico
core  

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

open access: yesMolecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia   +9 more
wiley   +1 more source

The History and Prediction of Prebiotics and Postbiotics: A Patent Analysis. [PDF]

open access: yesNutrients
Zang T   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy